Sign in to follow
Search Results

0 results for 'Mallinckrodt Pharmaceuticals'

You can use to get even better search results
In re Mallinckrodt PLC
Publication Date: 2022-04-12
Practice Area: Bankruptcy
Industry: Pharmaceuticals | State and Local Government
Court: U.S. District Court of Delaware
Judge: District Judge Stark
Attorneys:
For plaintiff:
For defendant:
Case number: D69780

Bankruptcy court properly authorized debtors' payment of professional fees incurred under a restructuring support agreement where payment of the fees advanced debtors' interests by facilitating resolution of legal claims against debtors and its Chapter 11 restructuring.

March 10, 2022 | Law.com

Compliance Hot Spots: SEC Pursues Novel Insider Trading Case + 'Hypocrisy' in White-Collar Crime Response + SDNY Vet Leads Russia Sanctions Task Force

The SEC is litigating what some observers are a calling a first-of-its-kind insider trading case against a pharma executive who allegedly bought stock in a rival company after hearing that his own company was about to be acquired.
13 minute read
March 03, 2022 | New York Law Journal

The Opioid Crisis: An Epidemic Exacerbated by Fraud

As Michael A. Sirignano discusses in this edition of his Insurance Fraud column, opioid fraud (or allegations of such fraud) reaches into nearly every segment of the industry, from prescribing physicians and medical staff to pharmacies, and results in significant financial losses to private insurance carriers and government health insurance programs including Medicare and Medicaid.
10 minute read
February 11, 2022 | Litigation Daily

Litigators of the Week: The Latham & Watkins Duo Who Paved the Path for Mallinckrodt to Exit Bankruptcy

Despite objections from the U.S. Trustee, the SEC, the state of Rhode Island and others, Latham's Chris Harris and Betsy Marks were able to get judicial sign-off on the pharma company's reorganization plan, including a $1.7 billion settlement of opioid-related litigation.
10 minute read
February 11, 2022 | Delaware Business Court Insider

Latham & Watkins Duo Talk Path to Mallinckrodt's Chapter 11 Reorganization in Del. Bankruptcy Court

Despite objections from the U.S. Trustee, the SEC, the state of Rhode Island and others, Latham's Chris Harris and Betsy Marks were able to get judicial sign-off on the pharma company's reorganization plan, including a $1.7 billion settlement of opioid-related litigation.
10 minute read
Law Journal Press | Digital Book Connecticut Foreclosures: An Attorney’s Manual of Practice and Procedure 2024 Authors: Denis R. Caron, Geoffrey K. Milne, Andrew P. Barsom View this Book

View more book results for the query "Mallinckrodt Pharmaceuticals"

January 06, 2022 | The Legal Intelligencer

Post-Petition Sales of Drug at Alleged Supracompetitive Price May Constitute Administrative Claims

As we ring in the New Year, we hope for a "fresh start" out of the pandemic, but recognize that challenges remain, including the latest variant. In the restructuring bar, we see new approaches being attempted to address old problems.
9 minute read
Horn v. Medical Marijuana Inc.
Publication Date: 2021-09-24
Practice Area: Damages
Industry: Pharmaceuticals
Court: U.S. District Court for the Western District of New York
Judge: District Judge Jonathan Feldman
Attorneys:
For plaintiff:
For defendant:
Case number: 15-CV-701

Fired Plaintiff's Earnings Loss Is Not Recoverable in Civil RICO Action

June 30, 2021 | New York Law Journal

Drugmakers Emphasize Government Responsibility, Impact of Cartels in New York Opioid Trial Opening Statements

Defense lawyers also sought to remind jurors that the international illegal drug trade, rather than pharmaceutical companies, is responsible for some of New York's drug issues.
4 minute read
June 29, 2021 | New York Law Journal

'Calculated Decision in Boardrooms' Led to Crisis, Lawyers Say in Opening NY Opioid Suit

Jurors were told during a lengthy opening statement that the defendants' old emails and marketing materials would demonstrate their culpability in the opioid crisis.
3 minute read
December 28, 2020 | New York Law Journal

Mired in Litigation, Opioid Makers File for Chapter 11

In this edition of his Bankruptcy Update, Edward E. Neiger focuses on Chapter 11 filings by opioid manufacturers, including Insys Therapeutics, Purdue Pharma and Mallinckrodt, as the industry faces a reckoning over its role in driving an addiction crisis in America and worldwide.
6 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now